NEW YORK (AP) — Bill Ackman's Pershing Square Capital Management, seeking legal cover in its $53 billion takeover bid for Allergan, filed a lawsuit to confirm that its push for a special meeting of shareholders won't trigger a defensive "poison pill" plan from the Botox maker.
from Business News Headlines - Yahoo! News http://ift.tt/1p14QI4
via IFTTT
from Business News Headlines - Yahoo! News http://ift.tt/1p14QI4
via IFTTT
No comments:
Post a Comment